Upcoming conferences

Come see us at the Molecular Med Tri-con, Booth 612
San Francisco - USA, February 11-16, 2018

Come see us at the 13th Annual Biomarkers Congress Booth 31
Manchester, UK, 15-16 February 2018

 

PAST CONFERENCES

What Can go wrong when Sourcing Biospecimens?
Webinar January 24, 2018, 1 pm to 2 pm ET

Trans-Hit Bio, invites you to our Webinar on Overcoming Problems When Sourcing Biospecimens.

Webinar Description:

Personalization of medicine is driving the increase in demand for high-quality and well-annotated biospecimens. Biospecimen sourcing is becoming a challenge for many scientists (academic and private) who need to respect timelines for R&D plans as well as regulatory and ethical constraints. Industry has access to different biospecimen sourcing channels, each one has its pros and cons: are the scientists working with the samples aware of all the imperatives to obtain them; quality according to state-of-the-art procedures, respect of laws, ethics and regulations?

This webinar will discuss real cases of issues with the sourcing of biospecimens and how they can affect R&D projects. It will underline the need for traceability on biospecimen sourcing. The compliance with country-specific ethical and regulatory standards will also be discussed.

Upon completion of this Webinar, attendees should be able to:

  • Understand the risks of not being able to trace human biospecimens (scientific conclusions drawn from studies, corporate risks);
  • Better select their biospecimen providers by asking the right questions.

Speaker:

Dr. Ann Cooreman, Ph.D.
Regulatory Affairs and Project Management
Trans-Hit Bio

Dr. Cooreman holds an MA from Antwerp University (Antwerp, Belgium), and a PhD from the University of Oregon (Eugene, OR). Following on from various postdoctoral fellowships, she started her career in the Biobank field as a Project Manager for Scottish Biomedical with the primary responsibility of setting up a Tissue Bank. Afterwards Ann co-founded and led an international commercial biobank (UK) where she had a variety of corporate, business development, and operational responsibilities. While there, she supervised hundreds of projects for high profile clients, establishing privileged relationships with the most prestigious academic clinical sites and biobanks. In 2015, Ann became an independent consultant in ethics and regulatory affairs advising a number of academic and commercial entities or regulatory bodies. Ann joined Trans-Hit Bio ‘s multi-national team in January 2017. She is responsible for overseeing regulatory, ethical, and quality assurance issues and has supervised hundreds of biospecimen procurement projects for dozens of clients. She is instrumental in the development of THB’s European branch, partnering with key clients and biorepositories. Based on her actual experience, good and bad, she will present to the audience what can go wrong when sourcing biospecimens.

Cost: No cost.

Registration: Please, click here to register.

Trans-Hit Bio to attend the Annual Biobank China 2017 
Changsha - China, Nov 30- December 3, 2017

Trans-Hit Bio participates at the Precision: Blood Cancer World R&D Summit
November 14-15, 2017 - San-Francisco – USA

Trans-Hit Bio  participates at the Precision: Blood Cancer World R&D Summit
November 14-15, 2017 - San-Francisco – USA

 

 

 

Trans-Hit Bio will present at the National Polish Biobank Conference

Wroclaw - Poland, October 13-14, 2017

Trans-Hit to attend the 2nd Annual Biomarkers & Precision Medicine USA Congress
San Diego, USA, 9-11 October

 

Come see us at Global Precision Medicine & Biomarkers leaders summit, Booth 1
Munich, Germany, September 21-22, 2017

 

 

Trans-Hit Bio to attend The Global Biobank Week
Stockholm, Sweden, September 13-15, 2017

 

Come see us at The Next Generation DX Summit, Booth 405
Washington, DC, August 15-18, 2017

Trans-Hit Bio will host a presentation at the Precision Lung Cancer Summit
Boston, July 25-26, 2017

 

Trans-Hit to attend the ASCO General Meeting
Chicago, IL, June 2-6, 2017

1) The importance of Reciprocal Transparency between Biobank and End Users of Samples
2) Tomorrow's need for Biospecimen in Pharma Research

 

 

 

Trans-Hit Bio attended: Global Precision Medicine Summit
Berlin, Germany, March 2-3, 2017

Trans-Hit Bio presented:
'How to expedite access to large biospecimen collections needed to validate liquid biopsy based assays' at The Molecular Medicine Tri Conference

San-Francisco, February 19-24, 2017. (Booth 605-607)

 

Trans-Hit Bio attended: 12th Annual Biomarkers Congress

Manchester, UK, February 21-22, 2017

Trans-Hit Bio Attended The ISBER 2016 Regional Meeting

Bethesda, MD, USA, November 7-8, 2016

Trans-Hit Attended The Europe Biobank Week
Vienna, Austria, September 13-16, 2016

Trans-Hit Attended The Next Generation DX Summit, Booth TT10

Washington, DC, USA, Augsut 23-26, 2016

Trans-Hit Hosted Two Presentations at The Biorepositories & Management Conference
Boston, MA, USA, September 5-7, 2016

Round table discussion:
Traceability of Biospecimen (patient - biobank - end-user): A need for Academic Biobank and Industry

Presentation:
Main impediments to increasing collaborations between Industry and Academic Biobank: some solutions